DOK, A CELL-LINE ESTABLISHED FROM HUMAN DYSPLASTIC ORAL-MUCOSA, SHOWS A PARTIALLY TRANSFORMED NONMALIGNANT PHENOTYPE

被引:109
作者
CHANG, SE [1 ]
FOSTER, S [1 ]
BETTS, D [1 ]
MARNOCK, WE [1 ]
机构
[1] ST BARTHOLOMEWS HOSP,DEPT MED ONCOL,ICRF,LONDON EC1A 7BE,ENGLAND
关键词
D O I
10.1002/ijc.2910520612
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There are many reports of cell lines being established from human oral squamous-cell carcinomas but apparently none of cell lines from dysplastic or "pre-malignant" oral mucosa. We describe here the isolation and characterization of a cell line, DOK (dysplastic oral keratinocyte), from a piece of dorsal tongue showing epithelial dysplasia. The tissue was obtained from a 57-year-old man who was a heavy smoker prior to the appearance of a white patch on his tongue. Eleven years later a squamous-cell carcinoma developed at the site and was excised. Subsequently the remaining dysplasia was removed, and it was from a piece of this that the primary cell cultures which eventually gave rise to DOK were initiated. The DOK line has been single-cell cloned and is apparently immortal. It grows in the absence of 3T3 feeder cells, is anchorage-dependent for growth and is non-tumorigenic in nude mice. The keratin profile of the cells shows a striking similarity to that of the original tongue dysplasia. The karyotype of DOK is aneuploid and complex. By PCR and oligonucleotide hybridization on dot blots, codons 12, 13 and 61 of Ha-ras, Ki-ras and N-ras in DNA extracted from DOK cells were shown to be normal. Immunohistochemistry showed no abnormal, i.e., elevated expression of the onco-suppressor protein p53. Because of its origin and partially transformed phenotype, DOK presents an opportunity to study whether specific carcinogens associated with tobacco and areca nut can cause malignant transformation of oral keratinocytes in vitro.
引用
收藏
页码:896 / 902
页数:7
相关论文
共 30 条
[1]   HUMAN JUNCTIONAL EPITHELIUM - DEMONSTRATION OF A NEW MARKER, ITS GROWTH-INVITRO AND CHARACTERIZATION BY LECTIN REACTIVITY AND KERATIN EXPRESSION [J].
BAMPTON, JLM ;
SHIRLAW, PJ ;
TOPLEY, S ;
WELLER, P ;
WILTON, JM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (05) :708-717
[2]   ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION [J].
BANKS, L ;
MATLASHEWSKI, G ;
CRAWFORD, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03) :529-534
[3]   RAS MUTATIONS IN UNITED-KINGDOM EXAMPLES OF ORAL MALIGNANCIES ARE INFREQUENT [J].
CHANG, SE ;
BHATIA, P ;
JOHNSON, NW ;
MORGAN, PR ;
MCCORMICK, F ;
YOUNG, B ;
HIORNS, L .
INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (03) :409-412
[4]  
CHANG SE, 1991, RISK MARKERS ORAL DI, V2, P340
[5]  
DURST M, 1987, ONCOGENE, V1, P251
[6]   CYCLIC-AMP IN RELATION TO PROLIFERATION OF EPIDERMAL-CELL - NEW VIEW [J].
GREEN, H .
CELL, 1978, 15 (03) :801-811
[7]  
GUSTERSON BA, 1991, ONCOGENE, V6, P1785
[8]   MONOCLONAL-ANTIBODIES SPECIFIC FOR SIMIAN VIRUS-40 TUMOR-ANTIGENS [J].
HARLOW, E ;
CRAWFORD, LV ;
PIM, DC ;
WILLIAMSON, NM .
JOURNAL OF VIROLOGY, 1981, 39 (03) :861-869
[9]   MONOCLONAL-ANTIBODIES PROVIDE SPECIFIC INTRAMOLECULAR MARKERS FOR THE STUDY OF EPITHELIAL TONOFILAMENT ORGANIZATION [J].
LANE, EB .
JOURNAL OF CELL BIOLOGY, 1982, 92 (03) :665-673
[10]   KERATIN ANTIGENS IN DIFFERENTIATING SKIN [J].
LANE, EB ;
BARTEK, J ;
PURKIS, PE ;
LEIGH, IM .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 455 :241-258